Briggs Morrison bought $227k of ARVN
director at ARVINAS, INC.. 30,000 shares at an average of $7.57, traded Sep 22, 2025, filed Sep 24, 2025.
Score components
- +15RoleDirector
- +13Trade size$227k at market
- +10Relative to holdingsHoldings up 65%
- +8Price context73% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-25-042536, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 22, 2025 | POpen-market purchase Common Stock | +30,000 | $7.57 | $227k | 76,021 | Sep 24, 2025 |
Related signals
Other insiders at ARVINAS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | ARVNsell ARVINAS, INC. | Noah Berkowitz Chief Medical Officer | $71k 6,435 shares | -3% | |
| 38Weak | ARVNbuy ARVINAS, INC. | Briggs Morrison director | $268k 20,000 shares | +26% | |
| 47Moderate | ARVINAS, INC. | John G Houston President and CEO | $466k 35,297 shares | -3% | |
| 47Moderate | ARVINAS, INC. | Randy Teel President and CEO | $58k 4,786 shares | -3% | |
| 36Weak | ARVINAS, INC. | Angela M Cacace Chief Scientific Officer | $44k 3,609 shares | -2% | |
| 30Weak | ARVINAS, INC. | David K Loomis Chief Accounting Officer | $13k 1,108 shares | -4% | |
| 30Weak | ARVINAS, INC. | David K Loomis Chief Accounting Officer | $12k 1,016 shares | -3% | |
| 38Weak | ARVINAS, INC. | Noah Berkowitz Chief Medical Officer | $68k 5,685 shares | -3% | |
| 37Weak | ARVINAS, INC. | Angela M Cacace Chief Scientific Officer | $55k 4,592 shares | -3% | |
| 44Moderate | ARVINAS, INC. | Andrew Saik Chief Financial Officer | $61k 5,134 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.